dulaglutide semaglutide Study shows semaglutide, tirzepatide and have similar gastrointestinal safety profiles in clinical settings Dulaglutide, #semaglutide, and #tirzepatide showed

Only recently have I started preparing to move to 7.5 mg, not because my calendar told me to, but because my body finally started giving me signs that it might be time

GHK-Cu peptide has been researched for its potential across a variety of functions (1) including that it may tighten and reverse the thinning of aging skin structure, supporting the extracellular matrix, that it may restore the skin barrier and moderate texture, hyperpigmentation and lesions, may support tissue repair and mitigate inflammation, may stimulate increasing hair follicle size, may exert antioxidant properties and, finally, may exhibit gene restructuring potential

GLP-1RAs, such as liraglutide, inhibit the PINK1/Parkin pathway and restrain excessive mitophagy, protecting RGCs from a high glucose environment

In some parts of the country, Black patients with diabetes are only half as likely as white patients to get GLP-1 drugs, according to research by Dr

[1] [2] The gastrointestinal effects tend to be most pronounced when treatment is initiated or when the dose is increased